DOCSLIB.ORG

Figure S1. Heat Map of GSE79973, Comparing Between 10 Gastric Cancer Tissues and 10 Normal Tissues

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Figure S1. Heat Map of GSE79973, Comparing Between 10 Gastric Cancer Tissues and 10 Normal Tissues Figure S1. Heat map of GSE79973, comparing between 10 gastric cancer tissues and 10 normal tissues. The GSE79973 included 10 patients. Every sample was from the same patient. These were patient 1 (32C,33N), patient 2 (34C,35N)….patient 9 (48C,49N), patient 10 (50C,51N), respectively. Columns with even numbers are for gastric cancer tissue and those with odd numbers are for normal tissues. C, cancer; N, normal. Figure S2. mRNA expression levels of histone modification‑ associated genes in different types of cancer according to the Oncomine database. Upregulation is indicated in red and downregulation in blue. Table SI. Basic characteristics and function of histone modification enzymes and associated genes. A, HDACs and associated genes Protein Gene Location Exon mass (kDa) Encoding protein and biological function HDAC1 1p35.2‑p35.1 14 55.11 Encodes a component of the HDAC complex. Interacts with retinoblastoma tumor‑suppressor protein and controls cell proliferation and differentiation. Together with metastasis‑associated protein‑2, it deacetylates p53 and modulates its effect on cell growth and apoptosis. HDAC2 6q21 17 55.37 Performs deacetylation of lysine residues at the N‑terminal regions of core histones (H2A, H2B, H3 and H4). Forms transcriptional repressor complexes by associating with proteins, including YY1. Participates in transcriptional regulation, cell cycle progression and developmental events. HDAC3 5q31.3 15 48.81 HDAC with a potential tumor suppressor gene function. Represses transcription when tethered to a promoter through its binding with YY1. Downregulates the function of p53 and modulates cell growth and apoptosis. HDAC4 2q37.3 37 106.39 Class II of the HDAC/AcuC/aphA family. Represses transcription; binds DNA through transcription factors MEF2C and MEF2D. Interacts with RbAp48 and HDAC3. HDAC5 17q21.31 30 122.02 Class II of the HDAC/AcuC/aphA family. Represses transcription. Coimmunoprecipitates only with HDAC3 family member. Interacts with MEF2 proteins to repress expression of MEF2‑dependent genes. HDAC6 Xp11.23 32 131.46 Class II of the HDAC/AcuC/aphA family. Contains an internal duplication of two catalytic domains, which appear to function independently of each other. Possesses HDAC activity to repress transcription. HDAC7 12q13.11 32 92.38 HDAC promoting repression mediated via the transcriptional corepressor SMRT. HDAC8 Xq13.1 16 41.76 Class I of the HDAC family, catalyzing the deacetylation of lysine residues in the histone N‑terminal tails, repressing transcription in large multiprotein complexes with transcriptional corepressors. HDAC9 7p21.1 38 111.33 HDAC family, repressing MEF2 activity through recruitment of multicomponent corepressor complexes that include CtBP and HDACs. This encoded protein may have a role in hematopoiesis. HDAC10 22q13.33 20 71.46 HDAC family, deacetylating lysine residues on the N‑terminal part of the core histones. HDAC11 3p25.1 14 39.19 Class IV HDAC, localized to the nucleus and may be involved in regulating the expression of interleukin 10. SIRT1 10q21.3 11 47.06 Class I of the sirtuin family. May function as intracellular regulatory proteins with mono‑ADP‑ribosyltransferase activity. SIRT2 19q13.2 17 39.52 Class I of the sirtuin family. May function as intracellular regulatory proteins with mono‑ADP‑ribosyltransferase activity. SIRT3 11p15.5 9 43.58 Class I of the sirtuin family. May function as intracellular regulatory proteins with mono‑ADP‑ribosyltransferase activity. SIRT4 12q24.23‑q24.31 5 35.19 Class IV of the sirtuin family. May function as intracellular regulatory proteins with mono‑ADP‑ribosyltransferase activity. SIRT5 6p23 15 33.89 Class III of the sirtuin family. May function as intracellular regulatory proteins with mono‑ADP‑ribosyltransferase activity. SIRT6 19p13.3 9 36.44 A member of the sirtuin family of NAD‑dependent enzymes that are implicated in cellular stress resistance, genomic stability, aging and energy homeostasis. Localized to the nucleus and exhibits ADP‑ribosyl transferase and HDAC activities. Participates in DNA repair, maintenance of telomeric chromatin, inflammation, as well as in lipid and glucose metabolism. SIRT7 17q25.3 11 44.9 Class IV of the sirtuin family. May function as intracellular regulatory proteins with mono‑ADP‑ribosyltransferase activity. Table SI. Continued. B, HATs and associated genes Protein Gene Location Exon mass (kDa) Encoding protein and biological function HAT1 2q31.1 12 49.52 A type B HAT that is involved in the rapid acetylation of newly synthesized cytoplasmic histones, which are in turn imported into the nucleus for de novo deposition onto nascent DNA chains. Histone acetylation, particularly of histone H4, has an important role in replication‑dependent chromatin assembly. Specifically, this HAT may acetylate soluble but not nucleosomal histone H4 at lysines 5 and 12, and to a lesser degree, histone H2A at lysine 5. KAT2A 17q21.2 18 93.94 Also known as GCN5. A HAT that functions primarily as a transcriptional activator. It also functions as a repressor of NF‑κB by promoting ubiquitination of the NF‑κB subunit RELA in a HAT‑independent manner. KAT2B 3p24.3 19 93.03 Possesses HAT activity. Associates with p300/CBP by binding to numerous sequence‑specific factors, including c‑jun or the adenoviral oncoprotein E1A, involved in cell growth and/or differentiation. Has a direct role in transcriptional regulation. KAT5 11q13.1 13 53.08 The MYST family of HATs, regulating chromatin remodeling, transcription and other nuclear processes by acetylating histone and nonhistone proteins. Participation in DNA repair and apoptosis. Important role in signal transduction. CREBBP 16p13.3 33 265.44 Transcriptional coactivation. Binding to CREB, this HAT acts as a scaffold to stabilize additional protein interactions with the transcription complex. Very high sequence similarity with protein p300 in its bromodomain, cysteine‑histidine‑rich regions, and HAT domain. Mutations in this gene cause RTS. Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. EP300 22q13.2 31 264.25 Encodes the adenovirus E1A‑associated cellular p300 transcriptional co‑activator protein. A HAT regulating transcription via chromatin remodeling, mediating cAMP gene regulation by binding specifically to phosphorylated CREB protein. A co‑activator of hypoxia‑inducible factor 1 alpha, thus stimulating hypoxia‑induced genes such as VEGF. Defects in this gene are a cause of RTS and may also have a role in epithelial cancer. TAF1 Xq13.1 45 20.89 Coordinating initiation of transcription by RNA polymerase II. The basal transcription factor TFIID, binding to core promoter sequences encompassing the transcription start site and also binding to activators and other transcriptional regulators. Contain two independent protein kinase domains at the N‑ and C‑terminals, but also possess acetyltransferase activity and may act as a ubiquitin‑activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X‑linked, a dystonia‑parkinsonism disorder. ELP3 8p21.1 18 The catalytic subunit of the HAT elongator complex, which contributes to transcript elongation and also regulates the maturation of projection neurons. NCOA1 2p23.3 24 156.8 A transcriptional coactivator for steroid and nuclear hormone receptors. A member of the p160/steroid receptor coactivator family, which has HAT activity and contains a nuclear localization signal, as well as bHLH and PAS domains. Also binds nuclear receptors directly and stimulates the transcriptional activities in a hormone‑dependent manner. NCOA2 8q13.3 32 159.2 A transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid and vitamin D receptors. Also an intermediary factor for the ligand‑dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. NCOA3 20q13.12 23 154.81 A nuclear receptor coactivator that interacts with nuclear hormone receptors to enhance their transcriptional activator functions. A HAT recruiting p300/CBP‑associated factor and CREB binding protein as part of a multisubunit coactivation complex. Table SI. Continued. B, HATs and associated genes Protein Gene Location Exon mass (kDa) Encoding protein and biological function CLOCK 4q12 28 Participates in the regulation of circadian rhythms. A transcription factor of the bHLH family that possesses DNA‑binding and HAT activity. Forms a heterodimer with ARNTL (BMAL1) that binds E‑box enhancer elements upstream of period circadian regulator 1, 2 and 3 and cryptochrome 1 and 2 genes, and activates transcription of these genes. Polymorphisms in this gene may be associated with behavioral changes in certain populations and with obesity and metabolic syndrome. C, HMT‑encoding and associated genes Protein Gene Location Exon mass (kDa) Encoding protein and biological function SMYD1 2p11.2 10 56.63 ‑ SMYD2 1q32.3 12 49.77 SET domain‑containing proteins, including SMYD2, catalyze lysine methylation. SMYD3 1q44 30 ‑ A HMT that functions in RNA polymerase II complexes by interaction with a specific RNA helicase. SMYD4 17p13.3 14 89.18 ‑ SMYD5 2p13.2 13 34.42 ‑ PRMT1 19q13.33 13 39.61 Table SI. Continued. C, HMT‑encoding and associated genes Protein Gene Location Exon mass (kDa) Encoding protein and biological function NSD1 5q35.3 31 267.39 Containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals, 4 PHD finger regions, and a proline‑rich region. Enhances androgen receptor transactivation. Acts as a nucleus‑localized,
Load more

Recommended publications
  • Core Transcriptional Regulatory Circuitries in Cancer
    Oncogene (2020) 39:6633–6646 https://doi.org/10.1038/s41388-020-01459-w REVIEW ARTICLE Core transcriptional regulatory circuitries in cancer 1 1,2,3 1 2 1,4,5 Ye Chen ● Liang Xu ● Ruby Yu-Tong Lin ● Markus Müschen ● H. Phillip Koeffler Received: 14 June 2020 / Revised: 30 August 2020 / Accepted: 4 September 2020 / Published online: 17 September 2020 © The Author(s) 2020. This article is published with open access Abstract Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type- specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics. 1234567890();,: 1234567890();,: Introduction genes. Till now, one critical goal in biology remains to understand the composition and hierarchy of transcriptional Transcriptional regulation is one of the fundamental mole- regulatory network in each specified cell type/lineage.
    [Show full text]
  • Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin
    cells Review Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin Agnieszka Bochy ´nska,Juliane Lüscher-Firzlaff and Bernhard Lüscher * ID Institute of Biochemistry and Molecular Biology, Medical School, RWTH Aachen University, Pauwelsstrasse 30, 52057 Aachen, Germany; [email protected] (A.B.); jluescher-fi[email protected] (J.L.-F.) * Correspondence: [email protected]; Tel.: +49-241-8088850; Fax: +49-241-8082427 Received: 18 January 2018; Accepted: 27 February 2018; Published: 2 March 2018 Abstract: Regulation of gene expression is achieved by sequence-specific transcriptional regulators, which convey the information that is contained in the sequence of DNA into RNA polymerase activity. This is achieved by the recruitment of transcriptional co-factors. One of the consequences of co-factor recruitment is the control of specific properties of nucleosomes, the basic units of chromatin, and their protein components, the core histones. The main principles are to regulate the position and the characteristics of nucleosomes. The latter includes modulating the composition of core histones and their variants that are integrated into nucleosomes, and the post-translational modification of these histones referred to as histone marks. One of these marks is the methylation of lysine 4 of the core histone H3 (H3K4). While mono-methylation of H3K4 (H3K4me1) is located preferentially at active enhancers, tri-methylation (H3K4me3) is a mark found at open and potentially active promoters. Thus, H3K4 methylation is typically associated with gene transcription. The class 2 lysine methyltransferases (KMTs) are the main enzymes that methylate H3K4. KMT2 enzymes function in complexes that contain a necessary core complex composed of WDR5, RBBP5, ASH2L, and DPY30, the so-called WRAD complex.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Dephosphorylation of HDAC4 by PP2A-Bδ Unravels a New Role For
    Veloso et et al. al.CellCell Death Death and and Disease Disease (2019) 10:512 (2019) 10:512 Page 1 of 16 https://doi.org/10.1038/s41419-019-1743-6 Cell Death & Disease ARTICLE Open Access Dephosphorylation of HDAC4 by PP2A-Bδ unravels a new role for the HDAC4/MEF2 axis in myoblast fusion Alexandra Veloso1,2, Maud Martin1,2,3, Jonathan Bruyr1,2,TinaO’Grady1,2, Christophe Deroanne1,4, Denis Mottet1,2, Jean-Claude Twizere1,2, Thomas Cherrier1,2,5 and Franck Dequiedt1,2 Abstract Muscle formation is controlled by a number of key myogenic transcriptional regulators that govern stage-specific gene expression programs and act as terminal effectors of intracellular signaling pathways. To date, the role of phosphatases in the signaling cascades instructing muscle development remains poorly understood. Here, we show that a specific PP2A-B55δ holoenzyme is necessary for skeletal myogenesis. The primary role of PP2A-B55δ is to dephosphorylate histone deacetylase 4 (HDAC4) following myocyte differentiation and ensure repression of Myocyte enhancer factor 2D (MEF2D)-dependent gene expression programs during myogenic fusion. As a crucial HDAC4/MEF2D target gene that governs myocyte fusion, we identify ArgBP2, an upstream inhibitor of Abl, which itself is a repressor of CrkII signaling. Consequently, cells lacking PP2A-B55δ show upregulation of ArgBP2 and hyperactivation of CrkII downstream effectors, including Rac1 and FAK, precluding cytoskeletal and membrane rearrangements associated with myoblast fusion. Both in vitro and in zebrafish, loss-of-function of PP2A-B55δ severely impairs fusion of myocytes and formation of multinucleated muscle fibers, without affecting myoblast differentiation. Taken together, our results establish PP2A-B55δ as the first protein phosphatase to be involved in myoblast fusion and suggest that reversible phosphorylation of HDAC4 may coordinate differentiation and fusion events during myogenesis.
    [Show full text]
  • Noelia Díaz Blanco
    Effects of environmental factors on the gonadal transcriptome of European sea bass (Dicentrarchus labrax), juvenile growth and sex ratios Noelia Díaz Blanco Ph.D. thesis 2014 Submitted in partial fulfillment of the requirements for the Ph.D. degree from the Universitat Pompeu Fabra (UPF). This work has been carried out at the Group of Biology of Reproduction (GBR), at the Department of Renewable Marine Resources of the Institute of Marine Sciences (ICM-CSIC). Thesis supervisor: Dr. Francesc Piferrer Professor d’Investigació Institut de Ciències del Mar (ICM-CSIC) i ii A mis padres A Xavi iii iv Acknowledgements This thesis has been made possible by the support of many people who in one way or another, many times unknowingly, gave me the strength to overcome this "long and winding road". First of all, I would like to thank my supervisor, Dr. Francesc Piferrer, for his patience, guidance and wise advice throughout all this Ph.D. experience. But above all, for the trust he placed on me almost seven years ago when he offered me the opportunity to be part of his team. Thanks also for teaching me how to question always everything, for sharing with me your enthusiasm for science and for giving me the opportunity of learning from you by participating in many projects, collaborations and scientific meetings. I am also thankful to my colleagues (former and present Group of Biology of Reproduction members) for your support and encouragement throughout this journey. To the “exGBRs”, thanks for helping me with my first steps into this world. Working as an undergrad with you Dr.
    [Show full text]
  • SMYD4 Antibody
    Efficient Professional Protein and Antibody Platforms SMYD4 Antibody Basic information: Catalog No.: UPA06235 Source: Rabbit Size: 50ul/100ul Clonality: Polyclonal Concentration: 1mg/ml Isotype: IgG Purification: The antibody was purified by immunogen affinity chromatography. Useful Information: WB: 1:500 - 1:2000 Applications: IHC: 1:50-1:200 IF/IC: 1:50-1:100 Reactivity: Human, Mouse Specificity: Recognizes endogenous levels of SMYD4 protein. Immunogen: Recombinant full length protein of human SMYD4 Description: Rabbit polyclonal antibody to SMYD4 Uniprot: Q8IYR2(Human), Q8BTK5(Mouse) BiowMW: Refer to Figures Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% Buffer: glycerol, and 0.01% sodium azide. Storage: Store at 4°C short term and -20°C long term. Avoid freeze-thaw cycles. Note: For research use only, not for use in diagnostic procedure. Data: Western blot analysis of SMYD4 expression in mouse brain (A), mouse ovary (B), rat kidney (C) whole cell lysates. Gene Universal Technology Co. Ltd www.universalbiol.com Tel: 0550-3121009 E-mail: [email protected] Efficient Professional Protein and Antibody Platforms Immunohistochemical analysis of SMYD4 staining in human stomach cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conju- gated compact polymer system. DAB was used as the chromogen. The section was then counter- stained with haematoxylin and mounted with DPX. Immunofluorescent analysis of SMYD4 staining in MCF7 cells. Formalin-fixed cells were permea- bilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature.
    [Show full text]
  • Tissue-Specific Splicing of a Ubiquitously Expressed Transcription Factor Is Essential for Muscle Differentiation
    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation Soji Sebastian,1 Herve´ Faralli,1,4 Zizhen Yao,2,4 Patricia Rakopoulos,1,3 Carmen Palii,1 Yi Cao,2 Kulwant Singh,1 Qi-Cai Liu,1 Alphonse Chu,1 Arif Aziz,1 Marjorie Brand,1,3 Stephen J. Tapscott,2 and F. Jeffrey Dilworth1,3,5 1Sprott Center for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, Ontario K1H 8L6, Canada,; 2Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; 3Department of Cellular and Molecular Medicine, University of Ottawa, Ontario K1H 8L6, Canada Alternate splicing contributes extensively to cellular complexity by generating protein isoforms with divergent functions. However, the role of alternate isoforms in development remains poorly understood. Mef2 transcription factors are essential transducers of cell signaling that modulate differentiation of many cell types. Among Mef2 family members, Mef2D is unique, as it undergoes tissue-specific splicing to generate a muscle-specific isoform. Since the ubiquitously expressed (Mef2Da1) and muscle-specific (Mef2Da2) isoforms of Mef2D are both expressed in muscle, we examined the relative contribution of each Mef2D isoform to differentiation. Using both in vitro and in vivo models, we demonstrate that Mef2D isoforms act antagonistically to modulate differentiation. While chromatin immunoprecipitation (ChIP) sequencing analysis shows that the Mef2D isoforms bind an overlapping set of genes, only Mef2Da2 activates late muscle transcription. Mechanistically, the differential ability of Mef2D isoforms to activate transcription depends on their susceptibility to phosphorylation by protein kinase A (PKA).
    [Show full text]
  • Supplementary Material and Methods
    Supplementary material and methods Generation of cultured human epidermal sheets Normal human epidermal keratinocytes were isolated from human breast skin. Keratinocytes were grown on a feeder layer of irradiated human fibroblasts pre-seeded at 4000 cells /cm² in keratinocyte culture medium (KCM) containing a mix of 3:1 DMEM and HAM’s F12 (Invitrogen, Carlsbad, USA), supplemented with 10% FCS, 10ng/ml epidermal growth factor (EGF; R&D systems, Minneapolis, MN, USA), 0.12 IU/ml insulin (Lilly, Saint- Cloud, France), 0.4 mg/ml hydrocortisone (UpJohn, St Quentin en Yvelelines, France) , 5 mg/ml triiodo-L- thyronine (Sigma, St Quentin Fallavier, France), 24.3 mg/ml adenine (Sigma), isoproterenol (Isuprel, Hospira France, Meudon, France) and antibiotics (20 mg/ml gentamicin (Phanpharma, Fougères, France), 100 IU/ml penicillin (Phanpharma), and 1 mg/ml amphotericin B (Phanpharma)). The medium was changed every two days. NHEK were then cultured over a period of 13 days according to the protocol currently used at the Bank of Tissues and Cells for the generation of clinical grade epidermal sheets used for the treatment of severe extended burns (Ref). When needed, cells were harvested with trypsin-EDTA 0.05% (Thermo Fisher Scientific, Waltham, MA, USA) and collected for analysis. Clonogenic assay Keratinocytes were seeded on a feeder layer of irradiated fibroblasts, at a clonal density of 10-20 cells/cm² and cultivated for 10 to 14 days. Three flasks per tested condition were fixed and colored in a single 30 mns step using rhodamine B (Sigma) diluted at 0.01 g/ml in 4% paraformaldehyde. In each tested condition, cells from 3 other flasks were numerated after detachment by trypsin treatment.
    [Show full text]
  • Genetic Regulation of Pigment Epithelium-Derived Factor (PEDF): an Exome-Chip Association Analysis in Chinese Subjects with Type 2 Diabetes
    198 Diabetes Volume 68, January 2019 Genetic Regulation of Pigment Epithelium-Derived Factor (PEDF): An Exome-Chip Association Analysis in Chinese Subjects With Type 2 Diabetes Chloe Y.Y. Cheung,1,2 Chi-Ho Lee,1 Clara S. Tang,3 Aimin Xu,1,2,4,5 Ka-Wing Au,1 Carol H.Y. Fong,1 Kelvin K.K. Ng,1 Kelvin H.M. Kwok,1 Wing-Sun Chow,1 Yu-Cho Woo,1 Michele M.A. Yuen,1 JoJo Hai,1 Kathryn C.B. Tan,1 Tai-Hing Lam,6 Hung-Fat Tse,1,7 Pak-Chung Sham,8,9,10 and Karen S.L. Lam1,2,4 Diabetes 2019;68:198–206 | https://doi.org/10.2337/db18-0500 Elevated circulating levels of pigment epithelium-derived (P = 0.085). Our study provided new insights into the factor (PEDF) have been reported in patients with type genetic regulation of PEDF and further support for its po- 2 diabetes (T2D) and its associated microvascular com- tential application as a biomarker for diabetic nephrop- plications. This study aimed to 1) identify the genetic athy and sight-threatening diabetic retinopathy. Further determinants influencing circulating PEDF levels in a studies to explore the causal relationship of PEDF with clinical setting of T2D, 2) examine the relationship be- diabetes complications are warranted. tween circulating PEDF and diabetes complications, and 3) explore the causal relationship between PEDF and di- abetes complications. An exome-chip association study Pigment epithelium-derived factor (PEDF) is a multifunc- on circulating PEDF levels was conducted in 5,385 Chi- tional glycoprotein that belongs to the serine protease nese subjects with T2D.
    [Show full text]
  • Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries Into Optimized Therapies Thai Hoa Tran1,2, Avanthi Tayi Shah3,4, and Mignon L
    Published OnlineFirst June 9, 2017; DOI: 10.1158/1078-0432.CCR-16-0115 Review Clinical Cancer Research Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies Thai Hoa Tran1,2, Avanthi Tayi Shah3,4, and Mignon L. Loh3,4 Abstract Survival of children with cancers has dramatically improved aberrant activation of signaling pathways, and epigenetic modi- over the past several decades. This success has been achieved fiers that can be targeted by novel agents. Thus, the recently through improvement of combined modalities in treatment described genomic and epigenetic landscapes of many child- approaches, intensification of cytotoxic chemotherapy for hood cancers have expanded the paradigm of precision med- those with high-risk disease, and refinement of risk stratifica- icine in the hopes of improving outcomes while minimizing tion incorporating novel biologic markers in addition to tra- toxicities. In this review, we will discuss the biologic rationale ditional clinical and histologic features. Advances in cancer for molecularly targeted therapies in genomically defined sub- genomics have shed important mechanistic insights on disease sets of pediatric leukemias, solid tumors, and brain tumors. biology and have identified "driver" genomic alterations, Clin Cancer Res; 23(18); 5329–38. Ó2017 AACR. Introduction which may represent actionable therapeutic targets. In this review, we will discuss how genomic discoveries are being translated from Survival rates for children diagnosed with cancer have the bench into the clinic, resulting in the development of precision improved substantially over the past five decades. Today, long- medicine trials for specific subtypes of pediatric hematologic term survival is expected for approximately 80% of children malignancies, solid tumors, and brain tumors.
    [Show full text]
  • Expression, Purification and Characterization of Lysine Methyltransferase Smyd5 Wen Xue Wayne State University
    Wayne State University Wayne State University Theses 1-1-2017 Expression, Purification And Characterization Of Lysine Methyltransferase Smyd5 Wen Xue Wayne State University, Follow this and additional works at: https://digitalcommons.wayne.edu/oa_theses Part of the Biochemistry Commons, and the Molecular Biology Commons Recommended Citation Xue, Wen, "Expression, Purification And Characterization Of Lysine Methyltransferase Smyd5" (2017). Wayne State University Theses. 596. https://digitalcommons.wayne.edu/oa_theses/596 This Open Access Thesis is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Theses by an authorized administrator of DigitalCommons@WayneState. Expression, Purification and Characterization of Lysine Methyltransferase SMYD5 by Wen Xue THESIS Submitted to the Graduate School Of Wayne State University, Detroit, Michigan In partial fulfillment of the requirements for the degree of MASTERS OF SCIENCE 2017 MAJOR: BIOCHEMISTRY AND MOLECULAR BIOLOGY Approved by: Advisor Date © COPYRIGHT BY WEN XUE 2017 All Rights Reserved DEDICATION To everyone who contributed to the better version of myself ii ACKNOWLEDGEMENTS I would like to thank all of my committee members, Dr. Zhe Yang, Dr. Ladislau Kovari, Dr. David Evans, for the academic support and advice they have provided to me throughout the last two years. I am very grateful to have met such an inspirational and kind group of individuals. All of you truly make the Wayne State University feel like a community for me. I would also like to say a very special thanks to my mentor Dr. Zhe Yang, who has taught me how to learn things and solve problems.
    [Show full text]
  • Gene Networks Activated by Specific Patterns of Action Potentials in Dorsal Root Ganglia Neurons Received: 10 August 2016 Philip R
    www.nature.com/scientificreports OPEN Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons Received: 10 August 2016 Philip R. Lee1,*, Jonathan E. Cohen1,*, Dumitru A. Iacobas2,3, Sanda Iacobas2 & Accepted: 23 January 2017 R. Douglas Fields1 Published: 03 March 2017 Gene regulatory networks underlie the long-term changes in cell specification, growth of synaptic connections, and adaptation that occur throughout neonatal and postnatal life. Here we show that the transcriptional response in neurons is exquisitely sensitive to the temporal nature of action potential firing patterns. Neurons were electrically stimulated with the same number of action potentials, but with different inter-burst intervals. We found that these subtle alterations in the timing of action potential firing differentially regulates hundreds of genes, across many functional categories, through the activation or repression of distinct transcriptional networks. Our results demonstrate that the transcriptional response in neurons to environmental stimuli, coded in the pattern of action potential firing, can be very sensitive to the temporal nature of action potential delivery rather than the intensity of stimulation or the total number of action potentials delivered. These data identify temporal kinetics of action potential firing as critical components regulating intracellular signalling pathways and gene expression in neurons to extracellular cues during early development and throughout life. Adaptation in the nervous system in response to external stimuli requires synthesis of new gene products in order to elicit long lasting changes in processes such as development, response to injury, learning, and memory1. Information in the environment is coded in the pattern of action-potential firing, therefore gene transcription must be regulated by the pattern of neuronal firing.
    [Show full text]